Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Uzabase Inc

Start price
Target price
Perf. (%)
€10.10
12.11.22
€4.00
12.11.23
0.99%
26.11.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
EBIT decline/stagnation expected
buy
Canadian National Railway Corp.

Start price
Target price
Perf. (%)
€119.50
12.11.22
€122.00
01.03.23
-8.64%
22.02.23

Revenue growth >5% per year expected
Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
High dividend yield expected
Oncopeptides AB

Start price
Target price
Perf. (%)
€1.96
12.11.22
€0.000
12.11.23
-17.89%
26.11.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Compass Inc.

Start price
Target price
Perf. (%)
€3.36
12.11.22
€1.00
12.11.23
-18.66%
26.11.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
High valuation
Bad rating
ShiftPixy Inc.

Start price
Target price
Perf. (%)
€18.00
12.11.22
€9.00
12.11.23
-12.22%
26.11.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Canadian National Railway Corp.

Start price
Target price
Perf. (%)
€119.50
12.11.22
€140.00
12.11.23
-12.55%
13.11.23

Could be worthwhile Investment >10% per year
High dividend yield expected
Top 10 in its market
Small cyclical dependencies
buy
ReneSola Ltd ADR

Start price
Target price
Perf. (%)
€4.61
11.11.22
-
11.11.23
9.76%
06.12.22

buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€124.30
11.11.22
€165.00
08.09.26
25.70%
06.09.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
positive Cash Flow expected
buy
Shop Apotheke Europe NV ADR

Start price
Target price
Perf. (%)
€4.92
11.11.22
€10.00
01.04.24
10.77%
10.01.23

buy
ASML Holding N.V.

Start price
Target price
Perf. (%)
€546.00
11.11.22
€700.00
01.04.24
4.95%
19.11.22

buy
Vitesco Technologies Group AG

Start price
Target price
Perf. (%)
€57.70
11.11.22
-
11.11.23
60.49%
12.11.23

buy
Voxeljet AG ADR

Start price
Target price
Perf. (%)
€2.48
11.11.22
€4.00
11.11.23
16.53%
11.11.22

Could be worthwhile Investment >10% per year
Stellantis N.V.

Start price
Target price
Perf. (%)
€14.11
10.11.22
€12.00
10.11.23
-5.36%
23.12.22

Could be worthwhile Investment >10% per year
buy
OHB SE

Start price
Target price
Perf. (%)
€30.80
10.11.22
-
10.11.23
35.55%
11.11.23

buy
Alibaba Group Holding Ltd ADR

Start price
Target price
Perf. (%)
€68.15
10.11.22
-
10.11.23
16.43%
30.11.22

buy
Austria Microsystems AG

Start price
Target price
Perf. (%)
€7.75
10.11.22
€11.00
10.11.23
-58.05%
11.11.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
buy
Bayer AG

Start price
Target price
Perf. (%)
€50.37
10.11.22
€70.00
10.11.25
-37.36%
06.09.24

buy
Masterflex

Start price
Target price
Perf. (%)
€8.42
10.11.22
-
10.11.23
6.89%
11.11.23

buy
Apple Inc.

Start price
Target price
Perf. (%)
€136.08
09.11.22
-
09.11.23
2.90%
06.12.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Very high dividend yield expected
EBIT growth > 30% per year expected
buy
3D Systems Corp.

Start price
Target price
Perf. (%)
€8.24
09.11.22
-
09.11.23
12.16%
30.11.22

buy
Commerzbank AG

Start price
Target price
Perf. (%)
€7.82
09.11.22
-
09.11.23
3.02%
23.11.22

buy
Commerzbank AG

Start price
Target price
Perf. (%)
€8.32
09.11.22
-
09.11.23
-6.03%
09.11.22

buy
Tesla Inc

Start price
Target price
Perf. (%)
€190.94
09.11.22
-
09.11.23
-9.83%
23.11.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Undervalued
buy
PNE AG

Start price
Target price
Perf. (%)
€20.45
09.11.22
-
09.11.23
-38.29%
10.11.23

Could be worthwhile Investment >10% per year
Small cyclical dependencies
Top 10 in its market
Growths faster than the competition
buy
Acelrx Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.91
08.11.22
€4.20
08.11.23
23.85%
16.11.22